← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Holding	Trade Value	Theme Stocks	% of Portfolio	Status
1976	TWMP Taylor Wealth Management Partners Boston, Massachusetts	$0	-$1.07M	0	–	Closed
1977	TCM Teza Capital Management Chicago, Illinois	$0	-$232K	0	–	Closed
1978	TA TFG Advisers Auburn Hills, Michigan	$0	-$60K	0	–	Closed
1979	TVWM Tower View Wealth Management Shorewood, Wisconsin	$0	$0	1	0%	Maintained
1980	TSS Two Sigma Securities New York	$0	-$2.27M	0	–	Closed
1981	VST Van Strum & Towne San Francisco, California	$0	-$222K	0	–	Closed
1982	Voleon Capital Management Berkeley, California	$0	-$4.28M	0	–	Closed
1983	Waldron Private Wealth Bridgeville, Pennsylvania	$0	-$212K	0	–	Closed
1984	WKWM Walter & Keenan Wealth Management Souh Bend, Indiana	$0	-$708K	0	–	Closed
1985	WTB Washington Trust Bank Spokane, Washington	$0	-$216K	0	–	Closed
1986	WCM Wealthcare Capital Management Richmond, Virginia	$0	-$15K	0	–	Closed
1987	WTFG Wells Trecaso Financial Group Akron, Ohio	$0	-$241K	0	–	Closed
1988	WC Wexford Capital West Palm Beach, Florida	$0	-$526K	0	–	Closed
1989	WBG Wharton Business Group Malvern, Pennsylvania	$0	-$302K	0	–	Closed
1990	WA Wheatland Advisors Lancaster, Pennsylvania	$0	-$694K	0	–	Closed
1991	WWM Willingdon Wealth Management Huntersville, North Carolina	$0	-$8K	0	–	Closed
1992	WA1 Wimmer Associates 1 Pasadena, California	$0	-$218K	0	–	Closed
1993	ZCM Zebra Capital Management Stamford, Connecticut	$0	-$50K	0	–	Closed
1994	ZP Zimmer Partners New York	$0	-$596K	0	–	Closed